Attached files

file filename
EX-99.1 - EX-99.1 - HOSPIRA INCa12-17100_1ex99d1.htm

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

July 25, 2012

Date of Report (Date of Earliest Event Reported)

 

HOSPIRA, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

1-31946

 

20-0504497

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

275 N. Field Drive
Lake Forest, Illinois 60045

(Address Of Principal Executive Offices, including Zip Code)

 

Registrant’s Telephone Number, Including Area Code:  (224) 212-2000

 

Not Applicable

(Former Name or Former Address, If Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On July 25, 2012, Dennis M. Fenton was elected to Hospira’s board of directors as a Class III director with a term expiring at the 2013 annual meeting of shareholders.  Dr. Fenton will serve on the board’s audit committee and science, technology and quality committee.  The press release announcing the election of Dr. Fenton to the board is attached as Exhibit 99.1 and is incorporated by reference into this Item 5.02.  Dr. Fenton will receive the standard non-employee director compensation for serving on the board.  For a description of that compensation, please see Hospira’s 2012 Proxy Statement, filed with the Securities and Exchange Commission on March 23, 2012.

 

Item 9.01

Financial Statements and Exhibits

 

(d)                           Exhibits

 

Exhibit No.

 

Exhibit

 

 

 

99.1

 

Press Release, dated July 31, 2012

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned  hereunto duly authorized.

 

 

 

HOSPIRA, INC.

 

 

 

 

Dated: July 31, 2012

/s/ Brian J. Smith

 

By:

Brian J. Smith

 

Its:

Senior Vice President, General Counsel

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Exhibit

 

 

 

99.1

 

Press Release, dated July 31, 2012

 

4